bf/NASDAQ:SAGE_icon.jpeg

NASDAQ:SAGE

Sage Therapeutics, Inc.

  • Stock

USD

Last Close

12.01

17/05 20:00

Market Cap

1.58B

Beta: 1.15

Volume Today

917.88K

Avg: 531.49K

PE Ratio

−2.29

PFCF: −2.65

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
90.27M
-
6.87M
92.39%
1.11B
16,123.06%
6.31M
99.43%
7.69M
21.85%
86.45M
1,024.84%
cost of revenue
400K
-
565K
41.25%
553K
2.12%
813K
47.02%
2.16M
165.56%
gross profit
90.27M
-
6.47M
92.84%
1.11B
17,117.61%
5.75M
99.48%
6.87M
19.43%
84.30M
1,126.48%
selling and marketing expenses
3.08M
-
5.27M
71.26%
11.18M
112.15%
44.60M
299.05%
general and administrative expenses
3.38M
-
9.71M
187.19%
25.29M
160.48%
39.41M
55.80%
62.88M
59.56%
201.40M
220.31%
345.78M
71.68%
196.95M
43.04%
183.50M
6.83%
227.70M
24.09%
274.52M
20.56%
selling general and administrative expenses
3.38M
-
9.71M
187.19%
25.29M
160.48%
39.41M
55.80%
62.88M
59.56%
201.40M
220.31%
345.78M
71.68%
196.95M
43.04%
183.50M
6.83%
227.70M
24.09%
274.52M
20.56%
research and development expenses
14.36M
-
24.10M
67.86%
69.36M
187.79%
120.76M
74.11%
210.28M
74.13%
282.11M
34.16%
368.81M
30.74%
292.71M
20.63%
283.17M
3.26%
326.16M
15.18%
356.24M
9.22%
other expenses
-3K
-
-9K
200%
-23K
155.56%
-35K
52.17%
-64K
82.86%
22K
134.38%
82K
272.73%
250K
204.88%
134K
46.40%
15K
88.81%
-383K
2,653.33%
cost and expenses
18.28M
-
33.81M
84.97%
94.65M
179.95%
160.16M
69.22%
273.15M
70.55%
483.51M
77.01%
714.99M
47.88%
490.23M
31.44%
467.22M
4.69%
554.67M
18.72%
632.92M
14.11%
operating expenses
18.28M
-
33.81M
84.97%
94.65M
179.95%
160.16M
69.22%
273.15M
70.55%
483.51M
77.01%
714.59M
47.79%
489.67M
31.48%
466.66M
4.70%
553.86M
18.69%
630.76M
13.88%
interest expense
8K
-
14.19M
-
ebitda
-18.23M
-
-33.81M
85.44%
-94.65M
179.95%
-160.16M
69.22%
-273.15M
70.55%
-393.24M
43.96%
-708.12M
80.08%
651.71M
192.03%
-460.91M
170.72%
-546.99M
18.68%
-511.68M
6.45%
operating income
-18.28M
-
-33.81M
84.97%
-94.65M
179.95%
-160.16M
69.22%
-273.15M
70.55%
-393.24M
43.96%
-708.12M
80.08%
596.23M
184.20%
-460.91M
177.30%
-546.99M
18.68%
-579.85M
6.01%
depreciation and amortization
47K
-
51K
8.51%
115K
125.49%
281K
144.35%
531K
88.97%
1.14M
115.25%
2.28M
99.74%
55.49M
2,330.40%
4.18M
92.46%
1.12M
73.17%
1.39M
24.15%
total other income expenses net
-9K
-
-23K
155.56%
-35K
52.17%
-64K
82.86%
22K
134.38%
27.89M
126,654.55%
9.85M
64.69%
3.02M
69.36%
14.21M
370.83%
-33.77M
337.73%
income before tax
-33.81M
-
-94.50M
179.48%
-158.99M
68.25%
-270.12M
69.90%
-372.88M
38.04%
-680.24M
82.43%
606.07M
189.10%
-457.89M
175.55%
-532.78M
16.36%
-541.49M
1.63%
income tax expense
2K
-
-59K
3,050%
-293K
396.61%
-1.49M
409.22%
-3.63M
143.30%
20.36M
660.77%
-30.09M
247.80%
15.52M
151.57%
-7.07M
145.53%
-29.52M
317.79%
-5.36M
81.85%
net income
-18.28M
-
-33.81M
84.95%
-94.50M
179.48%
-158.99M
68.25%
-270.12M
69.90%
-372.88M
38.04%
-650.15M
74.36%
606.07M
193.22%
-450.83M
174.38%
-503.27M
11.63%
-541.49M
7.59%
weighted average shs out
16.77M
-
21.57M
28.62%
27.78M
28.76%
33.47M
20.49%
38.10M
13.83%
46.12M
21.06%
50.83M
10.22%
51.98M
2.26%
58.67M
12.86%
59.31M
1.08%
59.84M
0.89%
weighted average shs out dil
24.96M
-
21.57M
13.57%
27.78M
28.76%
33.49M
20.57%
38.11M
13.80%
46.12M
21.01%
50.83M
10.22%
53.00M
4.27%
58.67M
10.69%
59.31M
1.08%
59.84M
0.89%
eps
-1.09
-
-1.57
44.04%
-3.40
116.56%
-4.75
39.71%
-7.09
49.26%
-8.08
13.96%
-12.79
58.29%
11.66
191.16%
-7.68
165.87%
-8.49
10.55%
-9.05
6.60%
epsdiluted
-0.73
-
-1.57
115.07%
-3.40
116.56%
-4.75
39.71%
-7.09
49.26%
-8.08
13.96%
-12.79
58.29%
11.43
189.37%
-7.68
167.19%
-8.49
10.55%
-9.05
6.60%

All numbers in USD (except ratios and percentages)